AngioDynamics (ANGO) Reports Q1 EPS of $0.17
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
AngioDynamics Reports Fiscal 2017 First Quarter Results
October 5, 2016 6:00 AM EDTQ1 net sales of $88.1 million, up 5% year-over-yearQ1 GAAP earnings per share of $0.04; non-GAAP adjusted EPS of $0.17Q1 operating cash generation of $7.4 millionFY2017 guidance remains unchanged
ALBANY, N.Y., Oct. 05, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today reported first quarter financial results for the 2017 fiscal quarter ended August 31, 2016.
Im pleased with our first quarter performance, which lays the foundation for... More
